AL-579

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAL-579
Drug Alias NameAL-579
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionIntercellular adhesion molecule-1 modulatorsLeukocyte adhesion glycoprotein LFA-1 alpha modulators
TargetsIntercellular adhesion molecule-1Leukocyte adhesion glycoprotein LFA-1 alpha
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEmory University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmory University
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantation

Other Information

ATC CodeN/A
Related LinksN/A